Crowdfunding in Singapore raises RM10.11 million needed to buy drug to treat baby with rare genetic disorder


Baby Zayn was diagnosed with Type 1 spinal muscular atrophy about five weeks after he was born. - PHOTO: SYAHIRAH YAKUB

SINGAPORE, Nov 12 (The Straits Times/ANN): A five-month-old boy facing immobility or even death because of a rare genetic disorder may get a new lease on life after his parents successfully raised the S$3 million (RM10.11 million) needed to treat his condition.

Baby Zayn – who was diagnosed with Type 1 spinal muscular atrophy (SMA) about five weeks after he was born – will be able to get the drug Zolgensma by early December, his parents, Mr Nabeel Salim Abdat and Ms Syahirah Yakub, told The Sunday Times.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Brunei strengthens waste collection services in national housing scheme
Haze in Singapore: PSI hits new high in west; air quality remains unhealthy across other regions
Japan to launch historic round-trip mission to Mars moon
Fans brave the heavy rain and haze to catch the K-pop superstars BigBang concert at Singapore National Stadium
Thousands flood US govt websites over steep post-grad work fee hikes
Indonesia restricts Mount Bromo viewpoint access amid forest fires
Pasir Gudang records highest API reading at 191 as of 10am
Why China is likely to be cautious about the recent Trump-Putin diesel deal
Trump press secretary Katie Zacharia says she passed bar exam in China, raising eyebrows
Helper’s arrest over death of elderly woman sparks calls for carer support

Others Also Read